Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China: An observational study

Hepatitis C virus (HCV) is one of the most important virus as the cause of liver disease in China. The aim of the present study was to explore whether sofosbuvir and ribavirin-based treatment can cure patients with chronic hepatitis C in eastern China. We examined a cohort of HCV-monoinfected patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao-Wei, Wu, Xiao-Xin, Chen, Ke-Da, Chen, Da-Zhi, Ou, Hui-Lin, Su, Jun-Wei, Yu, Hai-Ying, Yao, Hang-Ping, Li, Lan-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160050/
https://www.ncbi.nlm.nih.gov/pubmed/30235711
http://dx.doi.org/10.1097/MD.0000000000012403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160050/
https://www.ncbi.nlm.nih.gov/pubmed/30235711
http://dx.doi.org/10.1097/MD.0000000000012403

Ejemplares similares